Tyra Biosciences
TYRA
59 hedge funds and large institutions have $617M invested in Tyra Biosciences in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 0 closing their positions.
54% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 13
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
16% more funds holding
Funds holding: 51 → 59 (+8)
8% more capital invested
Capital invested by funds: $573M → $617M (+$43.7M)
1.07% more ownership
Funds ownership: 84.01% → 85.08% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.1M |
| 2 |
JP Morgan Chase
New York
|
+$3.35M |
| 3 |
BlackRock
New York
|
+$3.25M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$473K |
| 5 |
State Street
Boston,
Massachusetts
|
+$352K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$7.25M |
| 2 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$5.7M |
| 3 |
PA
Perceptive Advisors
New York
|
-$1.95M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$809K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$94.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AB
51
Amalgamated Bank
New York
| $27K | +$3.57K | +246 | +19% |
|
52
Legal & General Group
London,
United Kingdom
| $26.1K | +$1.84K | +127 | +9% |
|
|
AIP
53
Ameritas Investment Partners
Lincoln,
Nebraska
| $16K | – | – | – |
|
|
MLICM
54
Metropolitan Life Insurance Company (MetLife)
New York
| $13.9K | – | – | – |
|
|
TRCT
55
Tower Research Capital (TRC)
New York
| $11.2K | -$12.9K | -888 | -57% |
|
56
Simplex Trading
Chicago,
Illinois
| $11K | +$9.78K | +674 | New |
|
57
Russell Investments Group
London,
United Kingdom
| $3K | +$2.55K | +176 | New |
|
58
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $988 | – | – | – |
|
59
Nisa Investment Advisors
St. Louis,
Missouri
| $272 | – | – | – |
|
TYRA Hedge Fund Activity: Q2 2023 in Review
59 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Tyra Biosciences (TYRA) for Q2 2023, worth a combined $617M — up 7.6% from $573M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new TYRA positions and 0 closed out — a net gain of 8 holders — while 20 added to existing stakes and 13 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $14.1M. The largest seller was BVF Inc, cutting an estimated $7.25M.
- 59 institutional investors held Tyra Biosciences (TYRA) as of Q2 2023, up from 51 in Q1 2023.
- Funds reported $617M of Tyra Biosciences stock for Q2 2023, up 7.6% quarter-over-quarter.
- 8 funds opened new Tyra Biosciences positions in Q2 2023 and 0 closed out, a net change of +8 holders.
- The largest Tyra Biosciences buyer in Q2 2023 was Fidelity Investments, an estimated $14.1M added.
- The largest Tyra Biosciences seller in Q2 2023 was BVF Inc, an estimated $7.25M sold.
Based on aggregated 13F filings for Q2 2023.